Complaints Outcomes

Search

Search Results

Search Again
Lu, William Wanyang (Nov 30, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of William Wanyang Lu (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: November 30, 2018
  1. Name of registrant: William Wanyang Lu
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
     
  2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
     
  3. He knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
       
    2. There was no patient consent to process the transactions;
       
    3. Pharmacy assistants are always to be directly supervised; and
       
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
       
  4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If he fails to complete this within the specified time period, his registration will be suspended for a period of 30 days;
     
  2. To successfully pass the College’s Jurisprudence Exam;
     
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
     
  4. To have a Letter of Reprimand placed permanently on his registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Wong, Jason Jonathan (Nov 27, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Jason Jonathan Wong (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: November 27, 2018

  3. Name of registrant: Jason Jonathan Wong

  4. Location of Practice: Port Coquitlam, BC

  5. Admissions and Acknowledgements:

    Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

    These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

    The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

    The Registrant has admitted and/or acknowledged the following:

    1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
       
    2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
       
    3. He knew, or should have known, that:
      1. The processing of the transactions was an improper use and access of personal information;
         
      2. There was no patient consent to process the transactions;
         
      3. Pharmacy assistants are always to be directly supervised; and
         
      4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
         
    4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 60 days, commencing November 27, 2018;
       
    2. To successfully pass the College’s Jurisprudence Exam;
       
    3. To successfully complete and pass an ethics course for healthcare professionals;
       
    4. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association;
       
    5. To appear before the Inquiry Committee for a verbal reprimand; and
       
    6. To have a Letter of Reprimand placed permanently on his registration record.

     

  7. Rationale:

    The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

    The Inquiry Committee also considered that the Registrant had previously consented to remedial undertakings to fully comply with ethical requirements, and he had breached these undertakings for this current matter. The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required significant remediation and deterrence in order to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Tahmasebi Boldaji, Ashkan (Oct 10, 2018)

Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with Ashkan Tahmasebi Boldaji (the “Registrant”) to suspend his registration as a pharmacist for 30 consecutive days commencing December 4, 2018.

While the Registrant was delivering medications to a transitional housing complex the Registrant shoved and pushed a resident of this home out of an elevator resulting in her falling to the ground. The resident appeared to enter the elevator smoking a cigarette and did not put it out when asked by the Registrant. There was no evidence to support a need for self-defence by the Registrant. Additionally, the Registrant’s statements were found to be inconsistent with video evidence.

The Registrant acknowledged that his conduct constituted professional misconduct.

Pursuant to his Agreement, the Registrant also consented to the following:

  • To successfully complete an ethics course for healthcare professionals;
  • To appear before the Inquiry Committee for a verbal reprimand; and
  • To pay a $1000.00 fine.

The Inquiry Committee considers this agreement necessary to protect the public, and to send a clear message to the profession that the College does not tolerate this type of conduct.”

Pharmacy Technician Registrant 4 (Oct 3, 2018)

The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) has reached an agreement with the pharmacy technician registrant to voluntarily suspend her registration as pharmacy technician effective October 3, 2018. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacy technician’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 26 (Sep 3, 2018)

The Inquiry Committee, pursuant to section 36(1) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to further amend one of the terms in the Agreement of June 4, 2017. The Registrant can now work in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a monthly basis.


January 17, 2018
(September 3, 2018 - Limits and Conditions Updated)

The Inquiry Committee, pursuant to section 36(1) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to amend one of the terms in the Agreement of June 4, 2017. The pharmacist registrant can now work in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a biweekly basis.


June 4, 2017
(January 17, 2018 - Limits and conditions updated)

The Inquiry Committee, pursuant to section 36(1) of the Health Professions Act, has reached a new revised Agreement with the pharmacist registrant whereby the Registrant consented to undertakings that include, but are not limited to:

  1. Complying with all terms of the Registrant’s monitoring program for a minimum of three additional years;

  2. Continuing counselling for one year from the date after Registrant had returned to work;

  3. Informing all managers and employers with whom Registrant gains employment of registrant’s medical condition and the limits and conditions on Registrant’s registration pursuant to the Agreement;

  4. Ensuring that all managers and employers with whom Registrant gains employment submits a written statement to the College declaring their awareness of Registrant’s medical condition and the agreement, and how they will accommodate and supervise Registrant working in pharmacy;

  5. Working in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a weekly basis;

  6. Working a maximum number of hours and shifts per week for the first three months after signing the Agreement;

  7. Informing pharmacy manager of all wastages and breakages of narcotic, controlled, opioid and sedative drugs that the Registrant has to dispose of or deal with;

  8. Not conducting drug counts and/or conduct medication reconciliation for any narcotic/controlled substances or Z-group drugs;

  9. The Registrant will be restricted from acting in the following roles:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor;

     

  10. The Registrant will notify the College regarding any of the following changes:

    1. changes in places of employment as a pharmacist;
    2. changes in residential address and phone number; and
    3. changes in medical provider;

     

The Agreement will remain in place for a minimum of four years or until such time as the Registrant’s physician states otherwise. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant. The Inquiry Committee is satisfied that the undertakings will protect the public.


January 3, 2017
(June 4, 2017 – Limits and conditions updated)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended indefinitely on May 16, 2016. Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. That the Registrant will comply with all terms of Registrant’s monitoring program with the company currently involved in registrant’s care and remain on this program for a minimum of three (3) years from the day Registrant returns to active employment as a pharmacist;

  2. That Registrant will continue counselling for one (1) year after Registrant returns to work;

  3. That Registrant will inform all managers and employers with whom Registrant gains employment of registrant’s medical condition and the limits and conditions on Registrant’s registration pursuant to this agreement;

  4. That Registrant will ensure that all managers and employers with whom Registrant gains employment submit a written statement to the College within 48 hours of securing employment, declaring their awareness of Registrant’s medical condition and the agreement, how they will accommodate and supervise the Registrant working in the pharmacy, and that they will submit a weekly narcotic count for a minimum of three (3) months to the College or advise the College if any narcotic count concerns arise;

  5. That after returning to work in a pharmacy setting, Registrant will provide work sign-in sheets on a monthly basis;

  6. That Registrant will not work alone after returning to work in a pharmacy setting and that there must be overlapping shifts of at least one registrant during Registrant’s work shift for a minimum of the first six (6) months that Registrant returns to work;

  7. That after returning to work in a pharmacy setting, Registrant will not be allowed to dispense narcotics;

  8. That after returning to work in a pharmacy setting, Registrant will not handle or physically prepare prescriptions for narcotic, controlled, opioid and sedative drugs, including but not limited to Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs;

  9. That after returning to work in a pharmacy setting, for the first six (6) months, Registrant will not be allowed to dispense Controlled Substances ie. Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs (which are not considered Controlled Substances);

  10. That after returning to work in a pharmacy setting, Registrant will not be allowed to do narcotic or controlled substances or Z-Group drug counts;

  11. That after returning to work in a pharmacy setting, Registrant will not dispose or deal with wastage or breakage of or otherwise handle any narcotic, controlled, opioid and sedative drugs, including but not limited to Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs;

  12. That Registrant will not have access to the narcotic-safe or physically process and/or otherwise prepare any prescriptions that require access to the narcotic safe;

  13. That Registrant will not be involved in any way with ordering supplies of narcotic medications;

  14. That Registrant will be restricted from acting in the following roles in Registrant’s practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor;

     

  15. That Registrant will notify the College within 48 hours of such a change, in writing or via e-mail, of:

    1. all changes in places of employment as a pharmacist;
    2. all changes in residential address and phone number; and
    3. all changes in medical provider;

The Agreement will remain in place for a minimum of five years from the date of execution of the Agreement. The Registrant will be assessed by the treating physician after six (6) months upon return to active employment to determine whether or not any of the above limits or conditions should be removed. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.


May 16, 2016
(January 3, 2017 – Registration Reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist effective May 16, 2016. The agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The registrant's name has been withheld, pursuant to 39.3(4) of the Health Professions Act.

Zhao, David (Aug 19, 2018)

Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with David Zhao (the “Registrant”) to suspend his registration as a pharmacist for 365 consecutive days commencing September 4, 2018.

The Registrant acknowledged that between March 6, 2016 and January 18, 2017, while engaged in the practice of pharmacy as a pharmacist and pharmacy manager, he processed 526 false prescription claims to his insurance provider for reimbursement. The Registrant acknowledged that by processing false prescriptions, he also falsified pharmacy drug and inventory records.

The Registrant also acknowledged that while he was pharmacy manager, he was responsible for multiple practice deficiencies including processing prescriptions for his family members to artificially increase the pharmacy’s prescription count, engaging in a conflict of interest, and backdating prescriptions (meaning that dispensing records for these prescriptions were created on dates later than the dates on which the drugs in question were actually dispensed).

Prior to reinstatement of his registration following the suspension period, the Registrant will be required to:

  • Meet with the Inquiry Committee to discuss his reflections on his conduct and what he has learned; and
  • Complete an ethics course at his own expense.

The Registrant will also be limited from being a manager, direct owner and/or indirect owner of a pharmacy for a period of three years from the date his suspension ends (commencing September 4, 2019).

The Inquiry Committee considers this agreement necessary to protect the public, as well as send a clear message to the profession that the College does not tolerate this type of conduct. 

Phalore, Jagbir (Aug 3, 2018)

The Inquiry Committee has reviewed information that indicates Mr. Phalore’s practice is now meeting practice standards. Therefore, after reviewing and reconsidering this case, the Inquiry Committee determined that the current limits and conditions on Mr. Phalore’s practice are no longer necessary.

Limits and conditions on Mr. Phalore’s practice have now been removed.


November 29, 2016
(August 3, 2018 – Limits and conditions removed)

Pursuant to s. 35(4) of the Health Professions Act, the Inquiry Committee has determined that the limits and conditions imposed on the practice of pharmacy by Mr. Jagbir Phalore on May 16, 2016 are no longer necessary.

Pursuant to s. 36(1) of the Health Professions Act, the Inquiry Committee has reached an agreement with Mr. Phalore, effective November 29, 2016, where he undertaken to always follow certain steps in his pharmacy practice, and to disclose these undertakings to employers and potential employers. He will also be restricted from acting the following roles in his practice:

  1. Be an owner or manager of a pharmacy;
  2. Be a director of a corporation that owns a pharmacy; and
  3. Act as a preceptor.

After two years from November 29, 2016, Mr. Phalore may request that the Inquiry Committee remove the above limits and conditions, subject to a further review of the case by the Inquiry Committee.


May 16, 2016
(November 29, 2016 - Limits and conditions updated) 

The Inquiry Committee, pursuant to Section 35(1) of the Health Professions Act, R.S.B.C. 1996, c. 183, for the purposes of public protection, has imposed limits and conditions on the practice of registrant Jagbir Phalore, effective immediately, pending a Practice Audit of his pharmacy practice. Until further notice, Mr. Phalore has the following limits and conditions on his practice:

  1. At all times, he must work under the direct supervision of a BC licensed pharmacist in good standing, similar to a student/preceptor situation; 

  2. He will be restricted from acting in the following roles in his practice: :

    1. Be an owner or manager of a pharmacy;
    2. Be a director of a corporation that owns a pharmacy; and
    3. Act as a preceptor.

     

  3. Prior to the commencement of new employment at any pharmacy, he will inform every manager and employer of the pharmacy in which he gains employment of the limits and conditions on his license pursuant to this order, and will ensure that the pharmacy manager and employer submits a written statement to the College declaring their awareness of the limits and conditions and how the limits and conditions will be accommodated in the pharmacy.

The Inquiry Committee considered this action necessary to protect the public, due to its concerns regarding the registrant’s ability to practice safely and to comply with legislative requirements and practice standards in a hospital and/or community pharmacy setting.

Pharmacy Technician Registrant 2 (Jul 27, 2018)

The Inquiry Committee, pursuant to Section 32.2 of the Health Professions Act, has reached an agreement with pharmacy technician registrant to suspend her registration as a pharmacy technician for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pharmacist Registrant 34 (Jul 4, 2018)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously be suspended for an indefinite period on February 10, 2018.  Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings.  The undertakings include, but are not limited to:

  1. The Registrant will comply with any and all recommendations and treatment prescribed or directed by physician; and
     
  2. The Registrant will follow a regular monitoring program for medical condition for a two year period.  

The Agreement will remain in place until such time as the Registrant’s physician states otherwise. The name of the Registrant has been withheld in accordance with section 39.3(4) and (6) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant. The Inquiry Committee is satisfied that the undertakings will protect the public. 


Feb 10, 2018
(July 4, 2018 - Registration reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pharmacist Registrant 36 (Jun 10, 2018)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Pages